Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling

LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling

US Patent 11186838 · Granted Nov 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid compounds for binding to complement component 3 protein2022
IncRNAS for therapy and diagnosis of angiogenesis2022
LncRNAs for therapy and diagnosis of cardiac hypertrophy2022
LncRNAs for therapy and diagnosis of cardiac hypertrophy2022
Compound for treatment of heart failure2021
Natural compounds and fibrosis2021
Mitochondrial non-coding RNAs for predicting disease progression in heart failur2020
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes2019
LncRNAs for therapy and diagnosis of angiogenesis2019
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes2018
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes2017
Multiplexed analyses of test samples2016